Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920277 · ClinicalTrials.gov registry record
Ultrasound Image Collection for the Development of an AI Software
A clinical trial, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
- Completed
- Registry status
- 46
- Enrollment target
NCT06920277: Completed study, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
NCT06920277 is a clinical trial that has completed, run by Smart Alfa Teknoloji San. ve Tic. A.S.. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06920277 has completed, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This study is designed to collect ultrasound images from healthy volunteers in the U.S.
Primary Outcome
Ultrasound scans will be collected and reviewed for quality and completeness. The outcome will be the number of ultrasound recordings that meet predefined criteria for image quality; correct anatomical region and clear visualization to support AI development.
Interventions
- DEVICE Ultrasound scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2024-10-31 |
What the finished NCT06920277 record still lists
NCT06920277 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound scans is the first listed.
NCT06920277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06920277 about?
NCT06920277 is a clinical study titled "Ultrasound Image Collection for the Development of an AI Software". This study is designed to collect ultrasound images from healthy volunteers in the U.S.
What is the current status of trial NCT06920277?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2024-10-29. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT06920277?
The interventions under investigation include: Ultrasound scans (DEVICE).
Who is sponsoring clinical trial NCT06920277?
This trial is sponsored by Smart Alfa Teknoloji San. ve Tic. A.S., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI